Innovation
3 patent families — focus: Chemistry & metallurgy; filing pace active. Cited 13 times.
| Year | Filings |
|---|---|
| 2025 | 2 |
| 2026 | 1 |
Social engagement
Social engagement: 2.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
11 investors on record; lead investors include Canaan, Samsara BioCapital, Enavate Sciences.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 82% |
| Private equity | 1 | 9% |
| Other / undisclosed | 1 | 9% |
Recent activity
8 Jun 2026
Event
MIT CEO Conference
26 May 2026
Event
8th Annual Emerging Frontiers in Oncology
9 Apr 2026
Leadership hire
Chief Development Officer
